SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (4887)7/17/1998 4:40:00 PM
From: Steve Fancy   of 6136
 
Once again, in looking at the July options, I really can't see any relationship to the stock action today and options expiration. I think 1 3/4 points is a pretty healthy gain. I do expect it to head close to 30 ahead of earnings...strong rumors of one type or another could push it over. 28 is a hurdle, but we need to see the stock hold above it after earnings. Let's hope the news in the conference call is strong.

And no, we are not the only desperate longs who think it may be slightly oversold, but we are still certainly the minority...which was my only point when I was discussing "general sentiment" a week or two ago. The 33-35 range we were in before the Geneva conference seems like its a mile away at the moment.

sf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext